SK Life Science, Inc. Selects Patheon As Development Services Partner For...PharmaceuticalOnline: 1 views since Wednesday, July 9, 2008 at 09:01 AMPatheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, is pleased to have been selected by SK Life Science, Inc. (formerly known as SK Bio-Pharmaceuticals), the US-based subsidiary of Korean SK Holdings as their development services partner for two additional innovative Central Nervous System (CNS) drug candidates.
Published in: Chemical Services and Supplies